Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications

doi:10.1200/JCO.2015.64.4492

. 2016 Jun 20;34(18):2093-7.

doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications

Affiliations

¹ National Cancer Institute, Bethesda, MD maeve.mullooly@nih.gov.
² National Cancer Institute, Bethesda, MD.
³ University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
⁴ University of Texas Health Science Center, San Antonio, TX.
⁵ Group Health Research Institute, Seattle, WA.
⁶ Kaiser Permanente Northwest Center for Health Research, Portland, OR.

PMID: 27022110
PMCID: PMC4962703
DOI: 10.1200/JCO.2015.64.4492

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications

Maeve Mullooly et al. J Clin Oncol. 2016.

. 2016 Jun 20;34(18):2093-7.

doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28.

Affiliations

¹ National Cancer Institute, Bethesda, MD maeve.mullooly@nih.gov.
² National Cancer Institute, Bethesda, MD.
³ University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC.
⁴ University of Texas Health Science Center, San Antonio, TX.
⁵ Group Health Research Institute, Seattle, WA.
⁶ Kaiser Permanente Northwest Center for Health Research, Portland, OR.

PMID: 27022110
PMCID: PMC4962703
DOI: 10.1200/JCO.2015.64.4492

No abstract available

PubMed Disclaimer

Cited by

Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.
Huo CW, Waltham M, Khoo C, Fox SB, Hill P, Chen S, Chew GL, Price JT, Nguyen CH, Williams ED, Henderson M, Thompson EW, Britt KL. Huo CW, et al. Breast Cancer Res. 2016 Oct 25;18(1):106. doi: 10.1186/s13058-016-0767-4. Breast Cancer Res. 2016. PMID: 27776557 Free PMC article.
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.
Eriksson L, He W, Eriksson M, Humphreys K, Bergh J, Hall P, Czene K. Eriksson L, et al. JNCI Cancer Spectr. 2019 Jan 29;2(4):pky071. doi: 10.1093/jncics/pky071. eCollection 2018 Oct. JNCI Cancer Spectr. 2019. PMID: 31360886 Free PMC article.
Ultrasound tomography imaging with waveform sound speed: Parenchymal changes in women undergoing tamoxifen therapy.
Sak M, Duric N, Littrup P, Sherman M, Gierach G. Sak M, et al. Proc SPIE Int Soc Opt Eng. 2017 Mar;10139:101390W. doi: 10.1117/12.2254472. Proc SPIE Int Soc Opt Eng. 2017. PMID: 29046597 Free PMC article.
The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.
Knight JA, Blackmore KM, Fan J, Malone KE, John EM, Lynch CF, Vachon CM, Bernstein L, Brooks JD, Reiner AS, Liang X, Woods M; WECARE Study Collaborative Group; Bernstein JL. Knight JA, et al. Breast Cancer Res. 2018 Mar 22;20(1):23. doi: 10.1186/s13058-018-0948-4. Breast Cancer Res. 2018. PMID: 29566728 Free PMC article. Clinical Trial.
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.
Abubakar M, Mullooly M, Nyante S, Pfeiffer RM, Aiello Bowles EJ, Cora R, Bodelon C, Butler E, Butcher D, Sternberg L, Troester MA, Weinmann S, Sherman M, Glass AG, Berrington de Gonzalez A, Gierach GL. Abubakar M, et al. JNCI Cancer Spectr. 2022 May 2;6(3):pkac028. doi: 10.1093/jncics/pkac028. JNCI Cancer Spectr. 2022. PMID: 35583138 Free PMC article.

See all "Cited by" articles

References

1. Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–784. - PMC - PubMed
1. Jordan VC. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids. 2007;72:829–842. - PMC - PubMed
1. Boyd NF, Martin LJ, Yaffe MJ, et al. Mammographic density and breast cancer risk: Current understanding and future prospects. Breast Cancer Res. 2011;13:223. - PMC - PubMed
1. Huo CW, Chew GL, Britt KL, et al. Mammographic density-A review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479–502. - PubMed
1. Kim J, Han W, Moon HG, et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res. 2012;14:R102. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–784. - PMC - PubMed

[2] Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378:771–784. - PMC - PubMed

[3] Jordan VC. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids. 2007;72:829–842. - PMC - PubMed

[4] Jordan VC. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids. 2007;72:829–842. - PMC - PubMed

[5] Boyd NF, Martin LJ, Yaffe MJ, et al. Mammographic density and breast cancer risk: Current understanding and future prospects. Breast Cancer Res. 2011;13:223. - PMC - PubMed

[6] Boyd NF, Martin LJ, Yaffe MJ, et al. Mammographic density and breast cancer risk: Current understanding and future prospects. Breast Cancer Res. 2011;13:223. - PMC - PubMed

[7] Huo CW, Chew GL, Britt KL, et al. Mammographic density-A review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479–502. - PubMed

[8] Huo CW, Chew GL, Britt KL, et al. Mammographic density-A review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479–502. - PubMed

[9] Kim J, Han W, Moon HG, et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res. 2012;14:R102. - PMC - PubMed

[10] Kim J, Han W, Moon HG, et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res. 2012;14:R102. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications

Affiliations

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications

Authors

Affiliations

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

References

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical